Peconic Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History

Peconic Partners’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-433,587	Closed	-$19.8M	–	58
2017 Q4	$19.8M	Sell	433,587 -136,413	-24%	-$6.8M	2.85%	7
2017 Q3	$25.6M	Buy	+570,000	New	+$19.4M	4.12%	5
2017 Q2	–	Sell	-150,000	Closed	-$3.33M	–	65
2017 Q1	$3.33M	Buy	+150,000	New	+$3.22M	0.38%	23

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Peconic Partners's JUNO Position: Q1 2018 in Review

Peconic Partners sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 433,587 shares — an estimated $19.8M sold.

Peconic Partners first reported a position in JUNO in Q1 2017 and held it in 3 quarters. The position peaked at $25.6M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Peconic Partners reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Peconic Partners sold 433,587 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $19.8M.
Peconic Partners first reported a position in Juno Therapeutics, Inc. in Q1 2017 and held it in 3 quarters.
Peconic Partners's Juno Therapeutics, Inc. position peaked at $25.6M in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Peconic Partners's 13F filing for Q1 2018, filed 15 May 2018.